tiprankstipranks
Trending News
More News >
Haemonetics Corp. (HAE)
NYSE:HAE
US Market
Advertisement

Haemonetics (HAE) Ratios

Compare
399 Followers

Haemonetics Ratios

HAE's free cash flow for Q4 2025 was $0.58. For the 2025 fiscal year, HAE's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
2.44 2.56 3.06 1.71 2.74
Quick Ratio
1.62 1.50 2.03 1.05 1.46
Cash Ratio
0.72 0.60 1.13 0.59 0.76
Solvency Ratio
0.27 0.17 0.19 0.13 0.15
Operating Cash Flow Ratio
0.68 0.61 1.08 0.39 0.43
Short-Term Operating Cash Flow Coverage
5.76 17.77 23.17 0.80 6.39
Net Current Asset Value
$ -30.78M$ -466.73M$ -347.11M$ -354.28M$ -394.71M
Leverage Ratios
Debt-to-Assets Ratio
0.27 0.37 0.40 0.42 0.39
Debt-to-Equity Ratio
0.52 0.84 0.94 1.03 0.97
Debt-to-Capital Ratio
0.34 0.46 0.48 0.51 0.49
Long-Term Debt-to-Capital Ratio
0.33 0.45 0.48 0.43 0.49
Financial Leverage Ratio
1.91 2.29 2.37 2.48 2.49
Debt Service Coverage Ratio
4.64 9.95 8.46 0.68 4.40
Interest Coverage Ratio
8.43 12.67 10.67 4.72 3.44
Debt to Market Cap
0.08 0.19 0.18 0.24 0.12
Interest Debt Per Share
6.99 16.19 15.37 15.49 14.29
Net Debt to EBITDA
0.94 2.37 1.93 2.88 3.62
Profitability Margins
Gross Profit Margin
43.15%52.83%52.63%50.90%45.70%
EBIT Margin
8.63%12.60%13.35%8.13%10.31%
EBITDA Margin
19.94%20.29%21.34%17.97%16.34%
Operating Profit Margin
8.63%12.60%13.35%8.13%6.66%
Pretax Profit Margin
7.61%11.60%12.10%6.41%8.38%
Net Profit Margin
5.69%8.98%9.87%4.37%9.13%
Continuous Operations Profit Margin
5.69%8.98%9.87%4.37%9.13%
Net Income Per EBT
74.72%77.41%81.61%68.17%108.99%
EBT Per EBIT
88.14%92.10%90.62%78.80%125.79%
Return on Assets (ROA)
4.32%5.35%5.96%2.33%4.37%
Return on Equity (ROE)
8.24%12.25%14.11%5.79%10.86%
Return on Capital Employed (ROCE)
8.04%8.70%9.27%5.70%3.70%
Return on Invested Capital (ROIC)
5.85%6.70%7.51%3.36%3.97%
Return on Tangible Assets
5.88%9.60%9.67%4.01%8.04%
Earnings Yield
1.22%2.72%2.75%1.33%1.40%
Efficiency Ratios
Receivables Turnover
5.23 6.34 6.52 6.23 6.82
Payables Turnover
8.68 8.42 8.66 8.36 9.40
Inventory Turnover
2.83 1.95 2.13 1.66 1.46
Fixed Asset Turnover
2.81 3.57 3.76 3.84 4.00
Asset Turnover
0.76 0.60 0.60 0.53 0.48
Working Capital Turnover Ratio
4.06 2.65 2.81 2.64 2.29
Cash Conversion Cycle
156.71 201.73 184.82 234.19 263.79
Days of Sales Outstanding
69.80 57.60 55.95 58.57 53.49
Days of Inventory Outstanding
128.96 187.49 171.03 219.31 249.15
Days of Payables Outstanding
42.05 43.36 42.15 43.69 38.84
Operating Cycle
198.76 245.09 226.98 277.88 302.64
Cash Flow Ratios
Operating Cash Flow Per Share
3.09 3.58 5.38 3.37 2.15
Free Cash Flow Per Share
0.78 2.28 3.21 1.48 1.42
CapEx Per Share
2.31 1.31 2.17 1.89 0.73
Free Cash Flow to Operating Cash Flow
0.25 0.64 0.60 0.44 0.66
Dividend Paid and CapEx Coverage Ratio
1.34 2.74 2.48 1.78 2.94
Capital Expenditure Coverage Ratio
1.34 2.74 2.48 1.78 2.94
Operating Cash Flow Coverage Ratio
0.45 0.22 0.36 0.22 0.15
Operating Cash Flow to Sales Ratio
0.16 0.14 0.23 0.17 0.12
Free Cash Flow Yield
0.89%2.67%3.88%2.32%1.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
81.94 36.81 36.41 75.14 71.46
Price-to-Sales (P/S) Ratio
4.66 3.31 3.60 3.28 6.52
Price-to-Book (P/B) Ratio
6.75 4.51 5.14 4.35 7.76
Price-to-Free Cash Flow (P/FCF) Ratio
111.81 37.48 25.80 43.03 79.13
Price-to-Operating Cash Flow Ratio
28.30 23.81 15.39 18.92 52.20
Price-to-Earnings Growth (PEG) Ratio
3.36 16.71 0.22 -1.64 17.98
Price-to-Fair Value
6.75 4.51 5.14 4.35 7.76
Enterprise Value Multiple
24.30 18.66 18.78 21.14 43.55
Enterprise Value
4.69B 4.96B 4.68B 3.77B 6.19B
EV to EBITDA
24.30 18.66 18.78 21.14 43.55
EV to Sales
4.85 3.79 4.01 3.80 7.12
EV to Free Cash Flow
116.29 42.93 28.76 49.81 86.31
EV to Operating Cash Flow
29.44 27.27 17.15 21.91 56.93
Tangible Book Value Per Share
6.39 -0.22 1.50 -0.55 -1.98
Shareholders’ Equity Per Share
12.96 18.93 16.11 14.68 14.43
Tax and Other Ratios
Effective Tax Rate
0.25 0.23 0.18 0.32 -0.09
Revenue Per Share
18.78 25.82 23.01 19.46 17.17
Net Income Per Share
1.07 2.32 2.27 0.85 1.57
Tax Burden
0.75 0.77 0.82 0.68 1.09
Interest Burden
0.88 0.92 0.91 0.79 0.81
Research & Development to Revenue
0.04 0.04 0.04 0.05 0.04
SG&A to Revenue
0.30 0.32 0.32 0.34 0.31
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.02 0.03
Income Quality
2.90 1.55 2.37 3.97 1.37
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis